Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 9—September 2025
CME ACTIVITY - Research
Severe Group A Streptococcus Infection among Children, France, 2022–2024
Table 1
Clinical features of severe group A Streptococcus infections among 402 children, France, 2022–2024*
Clinical features | Value |
---|---|
Median age (IQR), y |
4 (2–7.5) |
Sex | |
M | 234 (58) |
F |
168 (42) |
Comorbidities | 52 (13) |
Immunosuppression |
7 (2) |
Viral infection in the previous 15 d | 109 (27) |
Influenza | 28/112 (25) |
Respiratory syncytial virus | 7/112 (6) |
Chicken pox | 37/112 (33) |
SARS-CoV-2 | 5/112 (4) |
Other |
37/112 (33) |
Isolated case | 326 (81) |
Isolated fever |
18 (4) |
Site of infection | |
Multiple | 146 (36) |
Ear-nose-throat | 135 (34) |
Skin and soft tissue | 63 (16) |
Bone and joint | 57 (14) |
Lower respiratory | 84 (21) |
Pleuro-pneumonia | 69 (17) |
Others† |
34 (8) |
Septic shock‡ | 34 (8) |
Toxic rash | 37 (9) |
*Values are no. (%) except as indicated. †Meningitis, endocarditis, peritonitis, dental cellulitis. ‡Defined as persistence of several organ failures or acute circulatory failure, failure to correct arterial hypotension despite vascular filling of >40 mL/kg, or both.
1Additional members who contributed data are listed at the end of this article.
Page created: July 11, 2025
Page updated: August 21, 2025
Page reviewed: August 21, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.